occurs in has participant quality has disease treated with drug INTERFERON ALFA-2A METHYLPREDNISOLONE ACETATE CYCLOSPORINE DESIPRAMINE TOLMETIN TRIMIPRAMINE ANASTROZOLE RITUXIMAB LEFLUNOMIDE VALGANCICLOVIR VALDECOXIB DAPTOMYCIN TOCILIZUMAB female breast cancer Cytomegalovirus retinitis endocarditis rheumatic disease mental depression rheumatoid arthritis osteoarthritis chronic myeloid leukemia psoriasis Elderly Child Adult abnormal blood pressure AE hypertension AE 10005750 10020772 CTCAE: E13785 WEB: http://www.ncbi.nlm.nih.gov/pubmed/21722707 SIDER: C0020538 YH, SS, MW MP: MP_0000231 NCIt: C3117 HPO: HP_0000822 blood pressure increased an abnormal blood pressure AE that has an outcome of sustained high blood pressure at a level that is likely to result in cardiovascular disease and/or other pathological states AE severity G1 AE severity G2 AE severity G3 AE severity G4 AE severity G5